Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 85 trials
NRG-BN011
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Adult (18-64)
Older adult (65+)
EA1181
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Adult (18-64)
Older adult (65+)
E4512
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Adult (18-64)
Older adult (65+)
A212102
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Adult (18-64)
Older adult (65+)
20180008
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
Adult (18-64)
Older adult (65+)
STR-001-001
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Adult (18-64)
Older adult (65+)
NCI-2017-01017
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Adult (18-64)
Older adult (65+)
S2209
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Adult (18-64)
Older adult (65+)
Child (birth - 17)
NCI-2014-02674
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Adult (18-64)
Older adult (65+)
NCI-2020-08331
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Adult (18-64)
Older adult (65+)